| scholarly article | Q13442814 |
| P50 | author | Elaine Jaffe | Q19647268 |
| Stefania Pittaluga | Q87358458 | ||
| Moses O Evbuomwan | Q114721616 | ||
| P2093 | author name string | Brian A Lewis | |
| Stella M Ranuncolo | |||
| P2860 | cites work | Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma | Q24613755 |
| Autophagy and NF-kappaB: fight for fate | Q24658157 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| Oncogenically active MYD88 mutations in human lymphoma | Q28301648 | ||
| Rescue of TRAF3-null mice by p100 NF-kappa B deficiency | Q28506895 | ||
| A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells | Q29547557 | ||
| Regulation and function of NF-kappaB transcription factors in the immune system | Q29616427 | ||
| A loss-of-function RNA interference screen for molecular targets in cancer | Q33237976 | ||
| TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma | Q33432504 | ||
| The regulatory logic of the NF-kappaB signaling system | Q33685419 | ||
| Selectivity of the NF-{kappa}B response | Q33752186 | ||
| Roles of the NF-kappaB pathway in lymphocyte development and function | Q33800318 | ||
| Oncogenic activation of NF-kappaB. | Q33849388 | ||
| Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. | Q33863064 | ||
| Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation | Q34034515 | ||
| Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. | Q34112913 | ||
| Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells | Q34274124 | ||
| Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. | Q34505714 | ||
| Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. | Q34520814 | ||
| Histopathology of Hodgkin's lymphoma | Q34977540 | ||
| Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development | Q35888216 | ||
| Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. | Q36155317 | ||
| Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs | Q36156167 | ||
| Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma | Q36375732 | ||
| Lymphoid organ development: from ontogeny to neogenesis | Q36426808 | ||
| Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. | Q37016499 | ||
| Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma | Q37314736 | ||
| The biology of Hodgkin's lymphoma | Q37349652 | ||
| Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma | Q37463052 | ||
| The NF-kappaB family of transcription factors and its regulation | Q37672294 | ||
| Non-canonical NF-κB signaling pathway | Q37822660 | ||
| TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. | Q38293065 | ||
| Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma | Q39370671 | ||
| Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome | Q39722611 | ||
| Oncogenic CARD11 mutations in human diffuse large B cell lymphoma | Q40005246 | ||
| Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts | Q40443980 | ||
| Regulation of NF-kappa B2 p100 processing by its cis-acting domain | Q40504235 | ||
| Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation | Q40566781 | ||
| Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma | Q40679662 | ||
| Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. | Q41206007 | ||
| NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening. | Q43004622 | ||
| Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling | Q43142702 | ||
| Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100. | Q46751773 | ||
| EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. | Q54441409 | ||
| High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells | Q71099795 | ||
| Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells | Q80786111 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hodgkin lymphoma | Q209369 |
| P304 | page(s) | 3756-3763 | |
| P577 | publication date | 2012-09-11 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival | |
| P478 | volume | 120 |
| Q47646877 | A link between RelB expression and tumor progression in laryngeal cancer |
| Q102054075 | A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma |
| Q36694809 | A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses. |
| Q34483490 | A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer |
| Q39155870 | Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblasts. |
| Q52340211 | Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives. |
| Q58704308 | Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma |
| Q59357963 | Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma |
| Q38596350 | Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma |
| Q36544675 | Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions |
| Q26749324 | European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia |
| Q92859346 | Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma |
| Q33918088 | Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB. |
| Q93386603 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer |
| Q38182355 | Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies |
| Q99414116 | Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future |
| Q54247368 | NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. |
| Q54147337 | NF-κB in Hematological Malignancies. |
| Q35095325 | NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression |
| Q38178074 | NF-κB pathways in hematological malignancies |
| Q38900549 | NIK is required for NF-κB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways |
| Q39040982 | Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma |
| Q37060378 | Prognostic significance of RelB overexpression in non-small cell lung cancer patients |
| Q39093157 | RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells |
| Q42444933 | RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow |
| Q38530616 | TRAF3, ubiquitination, and B-lymphocyte regulation. |
| Q91658641 | The Unsolved Puzzle of c-Rel in B Cell Lymphoma |
| Q89128308 | The aryl hydrocarbon receptor repressor - More than a simple feedback inhibitor of AhR signaling: Clues for its role in inflammation and cancer |
| Q46667078 | Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth |
| Q27341886 | Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration |
| Q26822486 | Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis |
Search more.